Medtronic plc (MDT) | Stock Overview & Key Data
Medtronic plc Performance Comparison
Stock Range
Today's Range
Low: $93.98
High: $95.74
on October 2, 2025
52 Week Range
Low: $79.29
High: $96.25
on December 30, 2024
on March 10, 2025
All-Time High: $135.89 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$121.9B
EPS
3.66
P/E Ratio (TTM)
26.02
Forward P/E
16.28
P/B Ratio
2.55
PEG Ratio
16.28
Div. Yield
3.27%
ROE
9.74%
Beta
0.788
Debt to Equity
59.44
Financial Highlights
Profitability
Gross Margin
65.02%
Operating Margin
18.69%
Profit Margin
13.63%
Returns and Earnings
Return on Assets (TTM)
4.57%
Return on Equity (TTM)
9.74%
EBITDA
$9.9B
Net Income (TTM)
$4.7B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$26.68
Quarterly Revenue Growth (YoY)
8.40%
Quarterly Earnings Growth (YoY)
-0.20%
Dividend Information
Last 12-Month Dividend
$2.80
Current Dividend Yield
3.27%
3-Year Average Dividend Yield
0.83%
3-Year Average Annual Dividend
$2.76
3-Year Total Dividends
$8.28
Ex-Dividend Date
March 28, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Medtronic plc MDT | 121.93B Large-cap | 1.25% | 2.30% | 8.16% | 7.45% | 19.02% | 8.18% | 15.85% | -12.15% |
| Abbott Laboratories ABT | 231.60B Mega-cap | -0.24% | 1.16% | -0.84% | 0.80% | 17.23% | 18.07% | 30.65% | 21.29% |
| Boston Scientific BSX | 142.83B Large-cap | -1.96% | -9.79% | -7.15% | -3.83% | 7.65% | 13.82% | 142.00% | 133.88% |
| Stryker SYK | 139.22B Large-cap | -0.59% | -6.04% | -6.49% | -2.93% | 2.14% | 4.32% | 75.71% | 64.36% |
| Edwards Lifesciences EW | 45.70B Large-cap | 1.83% | -6.26% | -0.48% | 6.38% | 5.59% | 17.04% | -9.00% | -8.64% |
| Dexcom DXCM | 26.16B Large-cap | -2.72% | -10.58% | -20.51% | -2.49% | -15.36% | -2.45% | -34.95% | -31.15% |
Ownership & Short Interest
Insider Ownership
0.30%
Institutional Ownership
87.29%
Shares Short
13M
Short Ratio
1.78
Short % of Shares Outstanding
1.00%
Average 10-Day Volume
8M
Average 90-Day Volume
7M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MDT's 52-week high and low?
- In the last 52 weeks, Medtronic plc reached a high of $96.25 (on March 10, 2025) and a low of $79.29 (on December 30, 2024).
- What is the market cap and P/E ratio for MDT?
- Curious about Medtronic plc's size and valuation? Its market capitalization stands at 121.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.02, and the forward P/E (looking ahead) is 16.28.
- Does MDT pay dividends? If so, what's the yield?
- Yes, Medtronic plc is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.27%, and the company has paid an average of $2.76 per share annually over the past 3 years.
- Who are Medtronic plc's main competitors or similar companies to consider before investing?
When looking at Medtronic plc, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT231.60B Healthcare Medical Devices 18.07% 30.65% Boston Scientific
BSX142.83B Healthcare Medical Devices 13.82% 142.00% Stryker
SYK139.22B Healthcare Medical Devices 4.32% 75.71% Edwards Lifesciences
EW45.70B Healthcare Medical Devices 17.04% -9.00% Dexcom
DXCM26.16B Healthcare Medical Devices -2.45% -34.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medtronic plc? (e.g., ROE, Debt/Equity)
- To get a sense of Medtronic plc's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.74%, the Debt to Equity ratio from the most recent quarter is 59.44, and its Gross Profit Margin stands at 65.02%.
- What is the recent revenue and earnings growth for MDT?
- Looking at Medtronic plc's growth, its revenue over the trailing twelve months (TTM) was $34B. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.40%, and quarterly earnings saw a YoY growth of -0.20%.
- How much of MDT stock is held by insiders and institutions?
- Wondering who owns Medtronic plc stock? Company insiders (like executives and directors) hold about 0.30% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 87.29%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.